|
|
|
Symbols |
Recent Price |
Market Cap |
Notes
|
|
ACHN |
1.44 |
40M |
HIV, Bacteria Infections. 1 in P2 and 3 in P1. Lift off soon. Huge
potential. |
|
ADLR |
1.65 |
76M |
Pain Management drugs $76M
Market cap. $110 in the bank. How can you go wrong? |
|
AEZS |
0.90 |
55M |
FDA decision Nov./09. Popped 27% 9/16/09 |
|
AGEN |
2.15 |
190M |
P2. Cancer Vaccine. Long shot. This could be a story stock some day but
which way? |
|
AKRX |
1.32 |
110M |
Diagnostic Substances .
Price/Sale: Only 1. Under-valued!!!! Strong buy |
|
ALTU |
0.32 |
10M |
Company is in a nine line bind. Only RODM can bring this patient back to
life in the blink of an eye.
Possible dead cat bounce to a whole buck!!!! |
|
ALXA |
2.77 |
96M |
Central nervous system. Six products in pipe line. One complete P3.
|
|
ANDS |
2.73 |
101M |
Hepatitis C, cancer... |
|
ANIK |
6.73 |
77M |
Money making
company. Good execution. Good pipe line. Good fortune. Already bounced! |
|
APPA
|
0.82 |
27M |
**** P3 completed. Can explode any minute. |
|
ARRY
|
2.85 |
135M |
Cancer, inflammatory, diabetes. P1, P2 |
|
ARYX
|
3.40 |
93M |
Cancer, |
|
ASTM |
0.42 |
67M |
|
|
ATHX |
0.96 |
18M |
At this price, ATHX stock is less than its cash per share. Stem
cell. |
|
AVII
|
2.05 |
175M |
Antisense and cancer immunotherapy technology |
|
AVNR |
2.21 |
173M |
P3 completed. |
|
BDSI |
4.80 |
99M |
1 approved. 1 P2. 1P1 |
|
BFRM
|
2.91 |
134M |
Medical Appliances &
Equipment. Profit trend looks good. Positive bottom line will drive
stock higher.
Don't expect a one day double here, but ...give it a year. |
BNVI
Bionovo |
0.89 |
68M |
Women health and cancer.
1 IND, 1on P1 and 1 on P2. Very promising. |
|
BPAX
|
1.91 |
64M |
Female sexual Health |
|
BSDM |
1.88 |
41M |
Medical Equipment |
|
CAPS
|
0.82 |
36M |
Peptides. Cash per share is higher than stock price. No debt.
Very low volume |
|
CLDX
|
5.34 |
85M |
Cancer Vaccines. May not double, but... how about 50%. Not a long term
play. |
|
CLSN
|
4.44 |
45M |
Oncology |
|
CRGN
|
1.37 |
79M |
Cancer. Long shot. Amazing story: From one-eyed sheep to cancer
cure. Being acquired. No
upside |
|
CRIS
|
2.22 |
147M |
Cancer |
|
CRXX |
1.56 |
53M |
FDA news 9/22. Stay out until
the dust settles |
|
CYCC
|
1.00 |
25M |
Cancer. |
|
CUR |
2.46 |
84M |
Up 30% 9/21/09 |
|
CYTK |
4.00 |
243M |
cardiovascular diseases and cancer |
|
CRTR
|
1.23 |
135M |
P1, P2. CYTR owns 39% of RXII |
|
DARA
|
0.49 |
16M |
2 diabetes and psoriasis, 2 products with IND
********************* |
|
DCGN
|
0.53 |
33M |
DNA-based diagnostic tests.
****** |
|
DCTH
|
5.07 |
133M |
chemotherapy and other therapeutic agents. P3 |
|
DDSS
|
1.46 |
83M |
Pain Management. Anti depression. FDA decision pending. |
|
DEPO |
4.00 |
208M |
Diabetes, Phase III clinical trial product for the treatment of
menopausal hot |
|
DRRX |
2.70 |
222M |
pain, central nervous system, disorders, cardiovascular disease.... |
|
DSCO |
0.86 |
103M |
FDA Meeting Sep. 29th, 2009. |
|
DUSA |
1.11 |
26M |
Dermatology. Has own products. Stock at 5 year low. |
|
DVAX |
2.22 |
88M |
Influenza, Hepatitis vaccines.P3 pending. May explode any minute. All it
takes is a PR. |
|
GENE |
1.79 |
23.5M |
IPO - Up 26% September 22, 2009 |
|
GNBT |
0.73 |
145M |
Diabetis, others... First IND approval September 09. Possible Block Buster!!!
Listen: GNBT at Rodman |
GNVC
Genvec |
0.75 |
76M |
Cancer, vaccines. Phase II/III ; P3 . Huge potential |
|
HEPH |
0.62 |
18M |
Hormones . Cancer. Diabetes. House cleaning in progress 9/09 |
|
HLCS |
2.93 |
185M |
Medical Equipment:
Gene Sequencing Systems. Buyout , merger candidate!!!!$$$$ |
|
HNSN |
4.19 |
157M |
Up 34% 09/21/09 |
|
ICGN |
1.18 |
55M |
Epilepsy, Pain, Asthma. P1, P2a |
|
IDIX |
3.08 |
|
|
|
IILI |
0.47 |
15M |
|
|
INHX |
1.18 |
51M |
Anti infection. Hepatitis C, HIV, herpes...
. ****************************** |
|
INSM |
0.87 |
111M |
Protein drugs. P3. |
|
JAV |
1.76 |
107M |
Pain Management |
|
KERX |
2.26 |
108M |
Orphan Status 9/16/09. Stock
popped 45% |
|
LGND |
2.43 |
275M |
Critical unmet medical needs. Lots of things going. P1, 2, 3. |
|
MBRK |
1.11 |
95M |
|
|
MNOV |
6.79 |
|
|
|
MSHL |
0.70 |
51M |
Cancer. P1, P2, P3 |
|
MTXX |
5.81 |
55M |
Stock dropped 70% July 09,
product recalled. Next Q earning could be hit hard. Put on watch
list!!! |
|
MYRX |
4.47 |
|
|
|
NABI |
3.23 |
|
|
|
NBIX |
3.03 |
|
|
|
NPSP |
4.42 |
|
|
|
NBY |
1.80 |
39.55M |
|
|
NRGN |
0.25 |
16M |
Psychiatric and Neurological disorders. P2. Cash in hand is more than
stock price. $$$$$$$$$ |
|
NTII |
0.90 |
24M |
Two products on P3.Stock is trading at cash value. This is a steal.
Dissolution in progress Sept 09 |
|
NURO |
3.03 |
43M |
Medical Equipment |
|
NVGN |
2.75 |
|
|
|
NXXI |
0.16 |
12M |
45M Revenue. Can't beat this! $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$ |
|
OCLS |
2.87 |
66M |
Skin Gel |
|
ONCY |
3.02 |
???? |
Popped 22% 9/18 |
|
ORCH |
1.62 |
51M |
DNA Testing Service.56M revenues, but losing money. |
|
ORXE |
0.60 |
4.05M |
This used to be Gene Logic. A cheap stock is cheap for some reasons and
can be cheaper. |
|
OSUR |
2.82 |
127M |
Medical Instruments &
Supplies |
|
OXGN |
1.42 |
89M |
P1. Cancer |
|
PCYC |
1.70 |
47M |
P1. Cancer |
|
PPHM |
0.82 |
187M |
Anti bodies for cancer and viral infections. |
|
PSDV |
4.20 |
76M |
2 Marketed products , 2 preclinical, 2 P2, 2P2, 1 P3 . Major
shareholder: PFE $$$$$$$ |
PTIE
PainTrials.com |
5.29 |
226M |
Pain |
|
QCOR |
5.96 |
|
|
|
QGLY |
2.36 |
30M |
Manufacturing, marketing, distribution
Drug Delivery |
|
QLTI |
4.31 |
236M |
ophthalmology. 126M sales |
|
RNN |
0.94 |
57M |
ophthalmology. 126M sales |
|
RPRX |
0.82 |
12.5M |
P2, P2a, P3 . Wow! Popped 30$ 9/18/09 |
|
RXII |
2.83 |
46M |
Obesity, Diabetes. |
|
SCLN |
4.42 |
205M |
cancer and infectious diseases in
China and internationally |
|
SCMP |
5.19 |
217M |
compounds ,gastrointestinal, vascular, respiratory, and central
nervous system diseases |
|
SLTM |
1.71 |
???? |
Medical Appliances &
Equipment |
|
SNMX |
3.74 |
115M |
flavor ingredients in the savory, sweet, salt, bitter |
|
SNTA |
3.15 |
107M |
Cancer, inflammatory. P1, P2 |
|
SNTS |
3.46 |
200M |
$140M sales. |
|
SOMX |
2.45 |
60M |
Insomnia . NDA resubmitted June 4th, 2009. FDA decision expected by
December or early 2010. |
|
SPEX |
1.95 |
28M |
Diabetes. P3. Popped 30% 9/16/09 |
|
STEM |
1.68 |
181M |
Stem cell technology |
|
SUPG |
2.87 |
168M |
Cancer, tumor. P3. Lot of cash |
|
TELK |
0.91 |
48M |
Small molecule drugs: Cancer, others |
|
THLD |
1.49 |
23M |
Cancer. P1/2 |
|
TOMO |
4.57 |
238M |
Radiation Therapy Equipment. |
|
TPI
|
4.20 |
73M |
China. Lots of products. |
|
TRBN |
5.16 |
93M |
Cancer |
|
TRMS |
2.62 |
58.5M |
Inhibitors for antiviral drug treatments. |
|
TTHI |
6.72 |
156M |
Alzheimer's disease, diabetes, .... P1, P2. Cash rich. |
|
VICL |
4.38 |
227M |
DNA-based vaccines, cancer... |
|
XOMA |
0.88 |
145M |
Definitely under-valued. Buy and Hold. |
|
XTNT.PK |
0.37 |
|
Medical Device. No sales. |
|
YMI |
1.61 |
90M |
Cancer. Popped 9/17/09 |
